Logo image of MGRM

MONOGRAM TECHNOLOGIES INC (MGRM) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:MGRM - US6097861081 - Common Stock

6 USD
-0.11 (-1.8%)
Last: 10/6/2025, 8:42:04 PM
6.2 USD
+0.2 (+3.33%)
After Hours: 10/6/2025, 8:42:04 PM

MGRM Key Statistics, Chart & Performance

Key Statistics
Market Cap243.78M
Revenue(TTM)N/A
Net Income(TTM)-18.45M
Shares40.63M
Float26.31M
52 Week High6.43
52 Week Low1.92
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.55
PEN/A
Fwd PEN/A
Earnings (Next)11-14 2025-11-14
IPO2023-05-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


MGRM short term performance overview.The bars show the price performance of MGRM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

MGRM long term performance overview.The bars show the price performance of MGRM in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100

The current stock price of MGRM is 6 USD. In the past month the price increased by 3.81%. In the past year, price increased by 150%.

MONOGRAM TECHNOLOGIES INC / MGRM Daily stock chart

MGRM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.29 219.41B
ISRG INTUITIVE SURGICAL INC 67.95 207.41B
BSX BOSTON SCIENTIFIC CORP 33.35 145.84B
SYK STRYKER CORP 27.88 140.43B
BDX BECTON DICKINSON AND CO 14.23 58.56B
IDXX IDEXX LABORATORIES INC 56.49 56.88B
EW EDWARDS LIFESCIENCES CORP 32.91 49.08B
GEHC GE HEALTHCARE TECHNOLOGY 19.21 40.16B
RMD RESMED INC 25.35 36.63B
DXCM DEXCOM INC 36.79 26.69B
PODD INSULET CORP 64.09 20.60B
ZBH ZIMMER BIOMET HOLDINGS INC 11.63 18.64B

About MGRM

Company Profile

MGRM logo image Monogram Technologies, Inc. is a medical technology company, which intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is headquartered in Warsaw Indiana, Indiana and currently employs 27 full-time employees. The company went IPO on 2023-05-18. The firm is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The firm's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The firm intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.

Company Info

MONOGRAM TECHNOLOGIES INC

345 East Main Street, Suite 307

Warsaw Indiana INDIANA US

Employees: 27

MGRM Company Website

MGRM Investor Relations

Phone: 15743733333

MONOGRAM TECHNOLOGIES INC / MGRM FAQ

What does MONOGRAM TECHNOLOGIES INC do?

Monogram Technologies, Inc. is a medical technology company, which intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is headquartered in Warsaw Indiana, Indiana and currently employs 27 full-time employees. The company went IPO on 2023-05-18. The firm is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The firm's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The firm intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.


Can you provide the latest stock price for MONOGRAM TECHNOLOGIES INC?

The current stock price of MGRM is 6 USD. The price decreased by -1.8% in the last trading session.


What is the dividend status of MONOGRAM TECHNOLOGIES INC?

MGRM does not pay a dividend.


How is the ChartMill rating for MONOGRAM TECHNOLOGIES INC?

MGRM has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is MONOGRAM TECHNOLOGIES INC (MGRM) stock traded?

MGRM stock is listed on the Nasdaq exchange.


What do analysts say about MONOGRAM TECHNOLOGIES INC (MGRM) stock?

7 analysts have analysed MGRM and the average price target is 8.57 USD. This implies a price increase of 42.8% is expected in the next year compared to the current price of 6.


Can you provide the PE ratio for MGRM stock?

MONOGRAM TECHNOLOGIES INC (MGRM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.55).


MGRM Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to MGRM. When comparing the yearly performance of all stocks, MGRM is one of the better performing stocks in the market, outperforming 97.04% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MGRM Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MGRM. While MGRM has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGRM Financial Highlights

Over the last trailing twelve months MGRM reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS decreased by -45.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -123.05%
ROE -214.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-45.45%
Sales Q2Q%N/A
EPS 1Y (TTM)-45.02%
Revenue 1Y (TTM)-100%

MGRM Forecast & Estimates

7 analysts have analysed MGRM and the average price target is 8.57 USD. This implies a price increase of 42.8% is expected in the next year compared to the current price of 6.


Analysts
Analysts82.86
Price Target8.57 (42.83%)
EPS Next Y2%
Revenue Next YearN/A

MGRM Ownership

Ownership
Inst Owners4.97%
Ins Owners19.29%
Short Float %N/A
Short RatioN/A